{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T14:55:42Z","timestamp":1792248942931,"version":"4.4.0"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2009,8,29]],"date-time":"2009-08-29T00:00:00Z","timestamp":1251504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2009,8,29]],"date-time":"2009-08-29T00:00:00Z","timestamp":1251504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1111\/j.1365-2133.2009.09484.x","type":"journal-article","created":{"date-parts":[[2009,8,29]],"date-time":"2009-08-29T07:16:59Z","timestamp":1251530219000},"page":"337-344","source":"Crossref","is-referenced-by-count":82,"title":["Long-term outcome of patients with polymyositis\/ dermatomyositis and anti-PM-Scl antibody"],"prefix":"10.1093","volume":"162","author":[{"given":"I.","family":"Marie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lahaxe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Benveniste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Delavigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Adoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mouthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Hachulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Constans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Tiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Diot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Jouen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,8,29]]},"reference":[{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(99)05157-0","article-title":"Dermatomyositis","volume":"355","author":"Callen","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.md.0000109755.65914.5e","article-title":"Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases","volume":"83","author":"Danko","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/art.10794","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"47","author":"Marie","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB4|cit4","first-page":"2230","article-title":"Polymyositis and dermatomyositis: short term and long term outcome, and predictive factors","volume":"28","author":"Marie","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/art.21083","article-title":"Opportunistic infections in polymyositis and dermatomyositis","volume":"53","author":"Marie","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005792-199905000-00001","article-title":"Influence of age on characteristics of polymyositis and dermatomyositis in adults","volume":"78","author":"Marie","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1172\/JCI108616","article-title":"Antinuclear antibody with distinct specificity for polymyositis","volume":"59","author":"Wolfe","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/art.20056","article-title":"PM-Scl-75 is the main autoantigen in patients with the polymyositis\/scleroderma overlap syndrome","volume":"50","author":"Raijmakers","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/ar389","article-title":"Autoantibodies directed to novel components of the PM\/Scl complex, the human exosome","volume":"4","author":"Brouwer","year":"2002","journal-title":"Arthritis Res"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1136\/ard.60.2.116","article-title":"Autoantibody profiles in the sera of European patients with myositis","volume":"60","author":"Brouwer","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2133.1990.tb01445.x","article-title":"Autoantibodies to nucleolar antigens in systemic sclerosis: clinical correlations","volume":"123","author":"Blaszczyk","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2340\/0001555571312316","article-title":"Clinical, serologic, and immunogenetic studies in patients with dermatomyositis","volume":"71","author":"Duncan","year":"1991","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1046\/j.1365-2133.1996.d01-1052.x","article-title":"Childhood sclerodermatomyositis: report of a case with the anti-PM-Scl antibody and mechanic\u2019s hands","volume":"135","author":"Garcia-Patis","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/art.1780330508","article-title":"Immunogenetic associations of scleroderma-related antinuclear antibodies","volume":"33","author":"Genth","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/08916930600622645","article-title":"Clinical implications of autoantibody screening in patients with autoimmune myositis","volume":"39","author":"Ghirardello","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/1529-0131(199707)40:7<1257::AID-ART10>3.0.CO;2-R","article-title":"Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies","volume":"40","author":"Hausmanowa-Petrusewicz","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.autrev.2007.01.013","article-title":"Novel aspects of autoantibodies to the PM\/Scl complex: clinical, genetic and diagnostic insights","volume":"6","author":"Mahler","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"R704","DOI":"10.1186\/ar1729","article-title":"Clinical evaluation of autoantibodies to a novel PM\/Scl peptide antigen","volume":"7","author":"Mahler","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB20|cit20","first-page":"155","article-title":"Principaux anticorps antinucl\u00e9aires et anticytoplasmiques au cours des polymyosites et des dermatomyosites. Etude de 42 observations","volume":"16","author":"Meyer","year":"1987","journal-title":"Presse Med"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/art.1780351014","article-title":"Serum autoantibody to the nucleolar antigen PM-Scl: clinical and immunogenetic associations","volume":"35","author":"Oddis","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/art.1780271011","article-title":"Multiplicity of antibodies in myositis sera","volume":"27","author":"Reichlin","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/BF00915286","article-title":"Antibodies to a nuclear\/nucleolar antigen in patients with polymyositis overlap syndromes","volume":"4","author":"Reichlin","year":"1984","journal-title":"J Clin Immunol"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/art.1780310409","article-title":"Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma)","volume":"31","author":"Reimer","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB25|cit25","first-page":"1729","article-title":"Anti-PM\/Scl autoantibodies in patients without clinical polymyositis or scleroderma","volume":"23","author":"Schnitz","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-3083.2004.00868.x","article-title":"PM-Scl autoantibody positive scleroderma with polymyositis (mechanic\u2019s hand: clinical aid in the diagnosis)","volume":"18","author":"T\u00f6r\u00f6k","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB27|cit27","first-page":"658","article-title":"Clinical relevance of PM-1 antibody and physiochemical characterization of PM-1 antigen","volume":"11","author":"Treadwell","year":"1984","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB28|cit28","first-page":"129","article-title":"Anti-PM\/Scl antibodies in connective tissue disease: clinical and biological assessment of 14 patients","volume":"24","author":"Vandergheynst","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB29|cit29","first-page":"2169","article-title":"Patients with antibodies to both PmScl and dsDNA","volume":"31","author":"Warner","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB32|cit32","first-page":"2706","article-title":"Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis","volume":"26","author":"Marie","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0272-5231(05)70111-8","article-title":"The lung in polymyositis","volume":"19","author":"Schwarz","year":"1998","journal-title":"Clin Chest Med"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/art.22237","article-title":"Myositis-specific and myositis-associated antibodies in a series of eighty-eight Mediterranean patients with idiopathic inflammatory myopathy","volume":"55","author":"Selva-O\u2019Callaghan","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.1780280303","article-title":"Prognostic factors in polymyositis\/dermatomyositis","volume":"28","author":"Benbassat","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-197707000-00001","article-title":"A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis","volume":"56","author":"Bohan","year":"1977","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/brain\/98.4.637","article-title":"Polymyositis: its presentation, morbidity and mortality","volume":"98","author":"De Vere","year":"1975","journal-title":"Brain"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0404.1982.tb03087.x","article-title":"Polymyositis - treatment and prognosis: a study of 107 patients","volume":"65","author":"Henriksson","year":"1982","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0301-0082(90)90026-D","article-title":"Polymyositis and dermatomyositis 1990 - diagnosis, treatment and prognosis","volume":"35","author":"Henriksson","year":"1990","journal-title":"Prog Neurobiol"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1136\/ard.52.12.857","article-title":"Adult onset polymyositis\/dermatomyositis: clinical and laboratory features and treatment response in 75 patients","volume":"52","author":"Koh","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB41|cit41","first-page":"1336","article-title":"Pulmonary involvement in polymyositis and in dermatomyositis","volume":"25","author":"Marie","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/art.1780140210","article-title":"Factors affecting survivorship in polymyositis: a life-table study of 124 patients","volume":"14","author":"Medsger","year":"1971","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/rheumatology\/keg253","article-title":"Anti-PM-Scl antibodies in a patient with inclusion body myositis","volume":"42","author":"Selva-O\u2019Callaghan","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB45|cit45","first-page":"438","article-title":"Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study","volume":"35","author":"Andr\u00e1s","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00051675","article-title":"Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark","volume":"6","author":"Chow","year":"1995","journal-title":"Cancer Causes Control"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MD.0b013e31819da352","article-title":"Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis","volume":"88","author":"Fardet","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(00)03540-6","article-title":"Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study","volume":"357","author":"Hill","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/01.bor.0000245721.02512.77","article-title":"Cancer and myositis: new insights into an old association","volume":"18","author":"Levine","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/art.1780330826","article-title":"HLA-D region genes associated with autoantibody responses to histidyl-tranfer RNA synthetase (Jo-1) and other translation-related factors in myositis","volume":"33","author":"Goldstein","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00005792-199211000-00001","article-title":"The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl","volume":"71","author":"Marguerie","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1164\/ajrccm.164.7.2103110","article-title":"Polymyositis-dermatomyositis-associated interstitial lung disease","volume":"164","author":"Douglas","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/art.23571","article-title":"Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology","volume":"59","author":"Fathi","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00002281-200011000-00005","article-title":"Interstitial lung disease in polymyositis and dermatomyositis","volume":"12","author":"Hirakata","year":"2000","journal-title":"Curr Opin Rheumatol"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/ard.46.1.23","article-title":"Pulmonary disease in polymyositis\/dermatomyositis: a clinicopathological analysis of 65 autopsy cases","volume":"46","author":"Lakhanpal","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2133.2009.09484.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1164\/ajrccm\/141.3.727","article-title":"Interstitial lung disease in polymyositis and dermatomyositis: clinical features and prognosis is correlated with histologic findings","volume":"141","author":"Tazelaar","year":"1990","journal-title":"Am Rev Respir Dis"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09484.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09484.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2009.09484.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T05:17:22Z","timestamp":1710566242000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/162\/2\/337\/6642342"}},"subtitle":["Long-term outcome in PM\/DM with anti-PM-Scl antibody"],"short-title":[],"issued":{"date-parts":[[2009,8,29]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09484.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8,29]]}}}